Shares of Cyclerion Therapeutics, Inc. (CYCN) are rising more than 13% Friday morning at $2.83.
As per SEC filing by Cyclerion on May 6, 2021, its CEO Peter Hecht has increased his stake by adding 698,001 shares of the company, at an average price of $2.43 per share for about $1.7 million.
CYCN has been trading in the range of $2.08- $8.96 in the past one year.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.